Bellevue Gold Limited (ASX:BGL)

Theseus Pharmaceuticals Revenue

Bellevue Gold had revenue of 222.34M AUD in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 471.68M, up 861.38% year-over-year. In the fiscal year ending June 30, 2024, Bellevue Gold had annual revenue of 298.41M.

• Revenue (ttm): 471.68M
• Revenue Growth: +861.38%
• P/S Ratio: 2.79
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	298.41M	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-